News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Ranbaxy Laboratories (RANBAXY.BO) Climbs on Lipitor Launch Buzz


9/8/2011 7:08:46 AM

Ranbaxy Laboratories Ltd. (RBXY) rose to its highest in a month after its parent said India’s largest drugmaker aims to start selling the generic version of Pfizer Inc. (PFE)’s cholesterol pill on schedule. Parent Daiichi Sankyo Co., Japan’s second-largest drugmaker, is working with the U.S. Food & Drug Administration to resolve issues related to two of its plants in India, and get an approval to market the drug in the North American nation, spokeswoman Michiko Harada said in an interview today.

Read at Bloomberg
Read at Reuters
Read at Money Control
Read at EconomicTimes

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES